Author Archives: admin
University of Utah, TikkunLev to accelerate heart-failure gene therapy
Salt Lake City – The University of Utah, one of the nation’s leading research universities, and TikkunLev Therapeutics, a gene therapy company, have announced a new partnership to accelerate an innovative heart failure gene therapy. The agreement is an exclusive world-wide license and includes a sponsored research program to support future FDA filings. The discovery […]
Carterra expands best-in-class franchise with the launch of the LSAXT high-throughput SPR biosensor at SLAS 2023
New instrument provides greater sensitivity to enable additional applications for discovery and characterization of novel therapeutics with unrivaled throughput and efficiency Salt Lake City, Utah —February 27, 2023—Carterra Inc., the world leader in innovative technologies enabling high-throughput biology, launched its latest HT-SPR instrument, the LSAXT, at the Society for Laboratory Automation and Screening (SLAS) Conference and […]
Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industry SALT LAKE CITY, March 02, 2023 (GLOBE NEWSWIRE) — Myriad Genetic, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the […]
BioUtah Recognizes Rare Disease Day 2023
BioUtah President and CEO, Kelvyn Cullimore, commented on Rare Disease Day held on February 28, 2023. “Today is Rare Disease Day 2023, a day being recognized in countries around the world. Here in Utah, Gov. Spencer J. Cox has declared February 28, 2023 Rare Disease Day in the state. We are marking this occasion with […]
SDNA Saliva Collection FDA 510(k) Class II Medical Device Clearance
SALT LAKE CITY, UTAH—Spectrum Solutions, LLC today announced the U.S. Food and Drug Administration (FDA) has granted 510(k) Class II clearance to the SDNA Saliva Collection Device as a microbial nucleic acid storage and stabilization device. The SDNA device is driving a new era of healthcare that turns to salivary collection and preservation as a […]
Merit Medical Receives FDA Breakthrough Device Designation for the New SCOUT® MD™ Surgical Guidance System
Next-generation system helps improve surgical precision to enhance patient care in breast and other soft tissue cancer treatment SOUTH JORDAN, Utah, Feb. 16, 2023 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today the FDA has granted Breakthrough Device Designation for the SCOUT MD […]
HHS Releases New Payment Models for Prescription Drugs
HHS released on Tuesday, three new payment models that will be tested through the Centers for Medicare & Medicaid Services Innovation Center (CMS Innovation Center) to see whether they lower high drug costs under Medicare and Medicaid. The models are outlined as part of a larger HHS report conducted in response to an executive order […]
BioUtah on Capitol Hill
The Utah State Legislature has hit its halfway point in the 2023 session. Since day one, BioUtah President and CEO, Kelvyn Cullimore, and industry lobbyist, Chris Bleak, have been on the Hill engaging with lawmakers on a number of issues that impact our industry. Yesterday, Cullimore testified before the House Health and Human Services Committee […]
Sumitomo Pharma Oncology Presented Preliminary Data From Phase 1/2 Clinical Study Evaluating Investigational Agent TP-3654 in Patients With Myelofibrosis at American Society of Hematology 2022 Annual Meeting & Exposition
Sumitomo Pharma Oncology presented new data from the ongoing Phase 1/2 study evaluating TP-3654.
Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in Multiple Sclerosis by Sanofi
SOUTH SAN FRANCISCO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier for the treatment of neurodegenerative diseases and lysosomal storage diseases, today announced that its partner Sanofi has commenced dosing in a Phase 2 study […]
UTAH’S LIFE SCIENCES INDUSTRY TAKES TO THE HILL
Utah’s vibrant life sciences industry was on full display January 27 as part of the Governor’s Office of Economic Opportunity “Life Sciences Day on the Hill”. The event, held at the state capitol, provided lawmakers the opportunity to interact one-on-one with leaders from local med tech, biotech and diagnostics companies. More than two dozen companies […]
BIOMERICS COMPLETES CONNECTICUT EXPANSION
SALT LAKE CITY, Jan. 20, 2023 /PRNewswire/ — Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced completion of a 26,000 sq. ft. expansion of its Monroe, CTfacility. The Monroe facility is the headquarters of Biomerics’ micro-metals processing business and specializes in the design, development, and manufacture of complex […]
